Research and Treatment

Research & Treatment

HemAware is conducting a series of interviews with recipients of the NHF-Shire Clinical Fellowship . It is funded through the...Read More
HemAware is conducting a series of interviews with recipients of the NHF-Shire Clinical Fellowship . It is funded through the...Read More
HemAware is conducting a series of interviews with recipients of the NHF-Shire Clinical Fellowship. It is funded through the generous...Read More
When the US Food and Drug Administration (FDA) approved Tivicay ® (dolutegravir), a new drug to treat HIV, in August...Read More
Update, November 2014: The St. Jude/UCL gene therapy trial now has data from all 10 participants, to be published in...Read More
HemAware is conducting a series of interviews with recipients of the NHF-Shire Clinical Fellowship . It is funded through the...Read More
This year’s mandatory federal budget cuts, known as “the sequester,” have been raising concerns about the future of biomedical research,...Read More
Research into treatments and cures for hemophilia takes place in laboratories all over the country. So it’s no wonder that...Read More
Cryoprecipitate. Long-acting factor concentrates. Gene therapy trials. These are just a few of the incredible clinical advances from the past...Read More
HemAware is conducting a series of interviews with recipients of the NHF-Shire Clinical Fellowship . It is funded through the...Read More
HemAware is conducting a series of interviews with recipients of the NHF-Shire Clinical Fellowship . It is funded through the...Read More
Five pilot sites have been approved and first patients enrolledRead More
Chat Icon
Need Info? Ask NHF!
Contact HANDI, NHF's resource center for additional information on bleeding disorders.